NM_000153.4:c.411_413delTAA
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM1PM2PM4_SupportingPP5_Very_Strong
The NM_000153.4(GALC):c.411_413delTAA(p.Lys138del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000686 in 1,458,380 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. A137A) has been classified as Likely benign.
Frequency
Consequence
NM_000153.4 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Publications
- Krabbe diseaseInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Myriad Women’s Health, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000153.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GALC | NM_000153.4 | MANE Select | c.411_413delTAA | p.Lys138del | disruptive_inframe_deletion | Exon 4 of 17 | NP_000144.2 | ||
| GALC | NM_001201401.2 | c.342_344delTAA | p.Lys115del | disruptive_inframe_deletion | Exon 3 of 16 | NP_001188330.1 | |||
| GALC | NM_001201402.2 | c.333_335delTAA | p.Lys112del | disruptive_inframe_deletion | Exon 4 of 17 | NP_001188331.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GALC | ENST00000261304.7 | TSL:1 MANE Select | c.411_413delTAA | p.Lys138del | disruptive_inframe_deletion | Exon 4 of 17 | ENSP00000261304.2 | ||
| GALC | ENST00000622264.4 | TSL:1 | c.399_401delTAA | p.Lys134del | disruptive_inframe_deletion | Exon 4 of 10 | ENSP00000480649.1 | ||
| GALC | ENST00000474294.6 | TSL:1 | n.401_403delTAA | non_coding_transcript_exon | Exon 4 of 10 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.86e-7 AC: 1AN: 1458380Hom.: 0 AF XY: 0.00000138 AC XY: 1AN XY: 725854 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Galactosylceramide beta-galactosidase deficiency Pathogenic:2Uncertain:1
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 555281). This variant is also known as K123del. This variant has been observed in individual(s) with Krabbe disease (PMID: 23197103, 26108647, 35286032). This variant is not present in population databases (gnomAD no frequency). This variant, c.411_413del, results in the deletion of 1 amino acid(s) of the GALC protein (p.Lys139del), but otherwise preserves the integrity of the reading frame.
Incidental Discovery Pathogenic:1
ACMG criteria used: PM2, PM3_strong, PM4.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at